Martin Röcken Selected Research

Dicyclohexylcarbodiimide (DCCD)

1/2018	The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival.
2/2014	Quantitative measurement of melanoma spread in sentinel lymph nodes and survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Röcken Research Topics

Disease

53	Neoplasms (Cancer) 01/2022 - 01/2005
19	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 01/2003
17	Melanoma (Melanoma, Malignant) 01/2022 - 07/2008
17	Inflammation (Inflammations) 01/2021 - 07/2003
17	Autoimmune Diseases (Autoimmune Disease) 10/2019 - 01/2003
10	Lymphoma (Lymphomas) 10/2021 - 07/2005
10	Hypersensitivity (Allergy) 01/2021 - 01/2005
8	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 05/2014
7	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2010
6	Carcinoma (Carcinomatosis) 01/2021 - 06/2008
6	Skin Diseases (Skin Disease) 09/2017 - 01/2002
6	Infections 11/2014 - 05/2002
5	Atopic Dermatitis (Atopic Eczema) 09/2017 - 01/2005
5	Dermatitis 01/2016 - 11/2005
4	Contact Dermatitis (Eczema, Contact) 01/2019 - 10/2002
4	Hypoxia (Hypoxemia) 01/2017 - 03/2008
3	Pemphigus (Pemphigus Vulgaris) 10/2019 - 04/2005
3	Multiple Sclerosis 10/2011 - 06/2004
3	Carcinogenesis 06/2008 - 01/2004
2	Encephalomyelitis (Myeloencephalitis) 01/2018 - 01/2017
2	Acidosis 01/2017 - 05/2012
2	Rheumatoid Arthritis 01/2017 - 06/2004
2	Bullous Pemphigoid (Pemphigoid) 12/2015 - 07/2012
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2015 - 10/2011
2	Necrosis 02/2013 - 06/2009
2	Arthritis (Polyarthritis) 05/2012 - 06/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2007 - 01/2007
2	Vitiligo 11/2005 - 01/2005
1	Anterior Uveitis 08/2022

Drug/Important Bio-Agent (IBA)

23	CytokinesIBA 08/2022 - 07/2002
14	AntigensIBA 01/2022 - 06/2004
10	Immune Checkpoint InhibitorsIBA 01/2022 - 10/2019
9	AntibodiesIBA 01/2022 - 05/2002
9	Interleukin-12 (IL 12)IBA 05/2021 - 11/2007
9	Interleukin-4 (Interleukin 4)IBA 02/2015 - 05/2002
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 11/2007
7	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 01/2003
5	Peptides (Polypeptides)IBA 05/2021 - 01/2005
4	AutoantigensIBA 01/2022 - 07/2003
4	VaccinesIBA 01/2022 - 08/2003
4	Interleukin-10 (Interleukin 10)IBA 10/2021 - 05/2014
4	Therapeutic UsesIBA 05/2021 - 03/2008
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2011
4	Interleukin-8 (Interleukin 8)IBA 01/2021 - 01/2003
4	InterferonsIBA 12/2020 - 04/2012
4	Dimethyl FumarateIBA 01/2018 - 08/2007
4	LigandsIBA 09/2015 - 07/2005
4	Interleukin-23 (Interleukin 23)IBA 02/2015 - 11/2007
4	FumaratesIBA 10/2011 - 06/2004
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 10/2008
3	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 09/2010
3	Oxygen (Dioxygen)IBA 01/2020 - 11/2011
3	OvalbuminIBA 01/2017 - 01/2015
3	Interleukin-17 (Interleukin 17)IBA 09/2015 - 11/2007
3	Type I Tumor Necrosis Factor ReceptorsIBA 02/2013 - 06/2008
2	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2018
2	InterleukinsIBA 01/2021 - 06/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2017
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 11/2018
2	NitrogenIBA 01/2021 - 01/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 10/2020
2	Mitogen-Activated Protein KinasesIBA 10/2020 - 09/2010
2	CTLA-4 AntigenIBA 10/2019 - 11/2018
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2015
2	Dicyclohexylcarbodiimide (DCCD)IBA 01/2018 - 02/2014
2	AllergensIBA 09/2017 - 01/2014
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2017 - 05/2012
2	fluoroazomycin arabinosideIBA 01/2017 - 11/2011
2	Biological ProductsIBA 01/2016 - 06/2004
2	Pharmaceutical PreparationsIBA 01/2016 - 03/2008
2	Toll-Like Receptor 2IBA 01/2016 - 07/2014
2	Matrix Metalloproteinases (MMPs)IBA 12/2015 - 01/2014
2	CholesterolIBA 09/2015 - 02/2014
2	Interleukin-2 (IL2)IBA 07/2015 - 06/2006
2	Interleukin-6 (Interleukin 6)IBA 11/2014 - 12/2011
2	AutoantibodiesIBA 07/2012 - 06/2007
2	Isotretinoin (Accutane)FDA LinkGeneric 05/2012 - 11/2008
2	ChemokinesIBA 04/2012 - 06/2008
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2012 - 05/2008
2	Imatinib Mesylate (Gleevec)FDA Link 07/2011 - 09/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2009 - 03/2008
2	AngiopoietinsIBA 06/2009 - 03/2008
2	Integrin beta3 (GPIIIa)IBA 06/2008 - 01/2005
2	Mitochondrial DNA (mtDNA)IBA 02/2007 - 12/2006
2	Thalidomide (Thalomid)FDA Link 01/2007 - 02/2003
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2006 - 01/2005
2	HaptensIBA 01/2005 - 10/2002
1	Mesalamine (Mesalazine)FDA LinkGeneric 08/2022
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 08/2022
1	palbociclibIBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	TransferasesIBA 04/2021

Therapy/Procedure

32	Therapeutics 01/2022 - 01/2003
13	Immunotherapy 01/2022 - 02/2014
5	Phototherapy (Light Therapy) 08/2016 - 01/2002
3	Lasers (Laser) 09/2010 - 02/2007
3	Photochemotherapy (Photodynamic Therapy) 11/2009 - 01/2004
2	Transplantation 01/2018 - 05/2007